Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verter

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|January 1, 1990
How much data should we collect in a randomized clinical trial?J Verter
Statistics in Medicine|January 1, 1990
Sickle cell anaemia trialM H Gaston, J Verter
Circulation|March 1, 1978
Disproportionate ventricular septal thickening in the developing normal human heartB J Maron, J Verter
Controlled Clinical Trials|August 1, 1991
Randomizing responders. Cardiac Arrhythmia Suppression Trial (CAST) investigatorsA P Hallstrom, J Verter, L Friedman
American Heart Journal|June 1, 1987
Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction StudyP H Frost, J Verter, D Miller
Neurologic Clinics|February 1, 1983
Current status of risk factors for strokeP A Wolf, W B Kannel, J Verter
JAMA|December 2, 1983
Manifestations of coronary disease predisposing to stroke. The Framingham studyW B Kannel, P A Wolf, J Verter
Annals of Internal Medicine|February 1, 1988
Cholesterol reduction and life expectancyP L Frommer, J Verter, J Witters, et al.
Clinical Cardiology|September 1, 1993
Thrombolytic therapy for unstable anginaS Borzak, J Verter, H S Bajwa, et al.
JAMA|November 27, 1996
Viability, morbidity, and resource use among newborns of 501- to 800-g birth weight. National Institute of Child Health and Human Development Neonatal Research NetworkJ E Tyson, N Younes, J Verter, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|January 1, 1990
How much data should we collect in a randomized clinical trial?J Verter
Statistics in Medicine|January 1, 1990
Sickle cell anaemia trialM H Gaston, J Verter
Circulation|March 1, 1978
Disproportionate ventricular septal thickening in the developing normal human heartB J Maron, J Verter
Controlled Clinical Trials|August 1, 1991
Randomizing responders. Cardiac Arrhythmia Suppression Trial (CAST) investigatorsA P Hallstrom, J Verter, L Friedman
American Heart Journal|June 1, 1987
Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction StudyP H Frost, J Verter, D Miller
Neurologic Clinics|February 1, 1983
Current status of risk factors for strokeP A Wolf, W B Kannel, J Verter
JAMA|December 2, 1983
Manifestations of coronary disease predisposing to stroke. The Framingham studyW B Kannel, P A Wolf, J Verter
Annals of Internal Medicine|February 1, 1988
Cholesterol reduction and life expectancyP L Frommer, J Verter, J Witters, et al.
Clinical Cardiology|September 1, 1993
Thrombolytic therapy for unstable anginaS Borzak, J Verter, H S Bajwa, et al.
JAMA|November 27, 1996
Viability, morbidity, and resource use among newborns of 501- to 800-g birth weight. National Institute of Child Health and Human Development Neonatal Research NetworkJ E Tyson, N Younes, J Verter, et al.
Pageof 4